Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report

Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report

Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis. Phase II studies have shown promising results, although long-term data are currently lacking. To address this, we analysed outcomes of patients with severe treatment-refractor...

Full description

Saved in:
Bibliographic Details
Main Authors: Tineke Kraaij, Cees van Kooten, Y K Onno Teng, Tom Huizinga, Eline J Arends, Robbert J Goekoop, Ton Rabelink, Mieke van Schaik, Marjolein J A L Wetzels, Stéphanie H Verbruggen, Sandra W van der Kooij, Sylvia W A Kamerling
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/12/1/e001424.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://lupus.bmj.com/content/12/1/e001424.full

Similar Items